Description: High density larynx and pharynx squamous cell carcinoma and larynx and pharynx tissue array, including pathology grade, TNM and clinical stage, 69 cases/207 cores

Description: Larynx and pharynx cancer tissue array, with matched and unmatched adjacent normal or cancer adjacent tissue, including pathology grade, TNM /stage (AJCC 8th edition),73 cases/80 cores, replaced by LP801a

Description: Larynx and pharynx cancer tissue array with unmatched normal tissues, 48 cases/48, cores with stage and grade data

Description: Single Donor Human Pharyngeal Swab

Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PHAR4 (C-term). This antibody is tested and proven to work in the following applications:

Description: Rabbit polyclonal P4HA1 antibody

Description: Rabbit polyclonal P4HA2 antibody

Description: A polyclonal antibody against P4HA1. Recognizes P4HA1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

Description: A polyclonal antibody against P4HA1. Recognizes P4HA1 from Human, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200

Description: A polyclonal antibody against P4HA2. Recognizes P4HA2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IP; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200, IP:1:200-1:2000

Description: A polyclonal antibody against P4HA2. Recognizes P4HA2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IP; Recommended dilution: IHC:1:20-1:200, IP:1:200-1:2000

Description: A polyclonal antibody against P4HA2. Recognizes P4HA2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

Description: A polyclonal antibody against P4HA3. Recognizes P4HA3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

Description: Human,Mouse,Rat

Description: Human,Mouse,Rat

Description: Human,Mouse,Rat

Description: Additional name(s) for this target protein: Proline 4-hydroxylase alpha 1

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Antibody raised against P4HA1

Description: Antibody raised against P4HA1

Description: Antibody raised against P4HA2

Description: Antibody raised against P4HA3

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: PHAP Antibody: Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after released from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activate procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and -7), which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-medicated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-medicated cell transformation.

Description: PHAP Antibody: Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after released from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activate procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and -7), which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-medicated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-medicated cell transformation.

Description: PHAP Antibody: Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after released from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activate procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and -7), which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-medicated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-medicated cell transformation.

Description: PHAP Antibody: Apoptosis is related to many diseases and development. Caspase-9 plays a central role in cell death induced by a variety of apoptosis activators. Cytochrome c, after released from mitochondria, binds to Apaf-1, which forms an apoptosome that in turn binds to and activate procaspase-9. Activated caspase-9 cleaves and activates the effector caspases (caspase-3, -6 and -7), which are responsible for the proteolytic cleavage of many key proteins in apoptosis. The tumor suppressor putative HLA-DR-associated proteins (PHAPs) were recently identified as important regulators of mitochondrion apoptosis. PHAP appears to facilitate apoptosome-medicated caspase-9 activation and to stimulate the mitochondrial apoptotic pathway. PHAP was also shown to oppose both Ras- and Myc-medicated cell transformation.

Description: Rabbit polyclonal PHAX antibody

Description: A polyclonal antibody against PHAX. Recognizes PHAX from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF; Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200

Description: A polyclonal antibody against PHAX. Recognizes PHAX from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

Description: A polyclonal antibody against PHAX. Recognizes PHAX from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.IHC:1/200-1/1000.ELISA:1/40000

Description: Available in various conjugation types.

Description: Available in various conjugation types.

Description: Rabbit polyclonal pH2AX antibody

Description: Rabbit polyclonal PHACS antibody

Description: Human,Mouse,Rat

Description: A polyclonal antibody against P4HA1. Recognizes P4HA1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Description: A polyclonal antibody against P4HA3. Recognizes P4HA3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Description: Available in various conjugation types.

Description: A polyclonal antibody against P4HA1. Recognizes P4HA1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

Description: A polyclonal antibody against P4HA3. Recognizes P4HA3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA